Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform

Name: Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform
License: Public Domain

Guangzhou Institute of Respiratory Disease

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

lung cancer non-small cell stage iv

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 287533
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.